Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.44 is in line with its 5-year average of 1.56, near the low end of its 5-year range (0.57–10.64).
As of the fiscal period ended Tuesday, June 30, 2026. 5.12% below its 12-month average of 1.52.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 1.44.
CURRENT RATIO
1.44
CURRENT RATIO AVG TTM
1.52
CURRENT RATIO AVG 3Y
1.28
CURRENT RATIO AVG 5Y
1.56
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.12%
CURRENT VS 3Y AVG
+12.35%
CURRENT VS 5Y AVG
-7.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.57
median of 739 covered companies
CURRENT VS SECTOR MEDIAN
-59.67%
vs the sector median at left
Intelligent Bio Solutions Inc.
Market Cap
$5.24M
Current Ratio
1.44
TTM Avg
1.52
3Y Avg
1.28
5Y Avg
1.56
Market Cap
$5.17M
Current Ratio
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
Market Cap
$5.15M
Current Ratio
1.88
TTM Avg
1.74
3Y Avg
1.99
5Y Avg
1.99
Market Cap
$5.23M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
Market Cap
$5.60M
Current Ratio
11.70
TTM Avg
17.23
3Y Avg
23.62
5Y Avg
22.05
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.24M | 1.44 | 1.52 | 1.28 | 1.56 |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | 4.70 | 11.62 | 9.04 | 8.74 |
| Alzamend Neuro Inc (ALZN)vs › | $5.25M | 3.01 | 3.95 | 2.52 | 4.28 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | 1.12 | 0.07 | 0.07 | 0.12 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.19 | 0.06 | 0.46 | 2.58 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.15M | 1.88 | 1.74 | 1.99 | 1.99 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | 0.09 | 0.18 | 0.44 | 0.97 |
| Imunon, Inc. (IMNN)vs › | $5.08M | 1.82 | 1.99 | 2.53 | 3.43 |
| enVVeno Medical Corporation (NVNO)vs › | $5.60M | 11.70 | 17.23 | 23.62 | 22.05 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | 2.35 | 1.31 | 0.84 | 0.78 |
Current Ratio
1.44
Quick Ratio
1.35
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.44 |
| 2026-03-31 | 2.11 |
| 2025-12-31 | 2.37 |
| 2025-09-30 | 0.89 |
| 2025-06-30 | 0.77 |
| 2025-03-31 | 1.12 |
| 2024-12-31 | 0.92 |
| 2024-09-30 | 1.57 |
| 2024-06-30 | 1.57 |
| 2024-03-31 | 2.02 |
| 2023-12-31 | 0.57 |
| 2023-09-30 | 0.66 |
| 2023-06-30 | 0.66 |
| 2023-03-31 | 1.32 |
| 2022-12-31 | 1.32 |
| 2022-09-30 | 2.33 |
| 2022-06-30 | 2.90 |
| 2022-03-31 | 3.51 |
| 2021-12-31 | 5.60 |
| 2021-09-30 | 4.94 |
| 2021-06-30 | 10.64 |
| 2021-03-31 | 17.12 |
| 2020-12-31 | 17.12 |
| 2020-09-30 | 0.49 |
| 2020-06-30 | 0.06 |
| 2020-03-31 | 0.01 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.44 |
| 2019-06-30 | 0.37 |
| 2019-03-31 | 0.34 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.45 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
